Cardio USMLE 9-22 (1) Flashcards
This patient, who recently received a diagnosis of congestive heart failure with a reduced ejection fraction, is taking a diuretic. It is very likely a potassium-sparing diuretic, such as spironolactone, because potassium-sparing diuretics are mainstays in the management of this patient’s type of heart failure. Additionally, this patient is presenting with symptoms of hyperkalemia (ascending flaccid muscle paralysis) and ECG changes that are reflective of hyperkalemia, such as peaked T waves and a widened QRS interval and sinus bradycardia.
Because spironolactone is a potassium-sparing diuretic, it will cause potassium to be reabsorbed and sodium to be excreted at higher than normal rates. Given this and the fact that some water will follow the sodium, the most likely urine findings would be?
low K+, elevated Na+, and a high-normal urine volume.
Because potassium-sparing diuretics reduce the secretion of potassium in the collecting ducts, more potassium will be retained and less will be excreted in the urine. Thus any answer that includes no change in or an increase in K+ in the urine is incorrect. Also, because diuretics work by increasing sodium excretion, any answer that includes no change in or a decrease in urine Na+ is incorrect. Also, because water will follow sodium, there would be an increased urine volume (initially), and thus any answer that includes no change in or a decrease in urine volume is incorrect.
Potassium-sparing diuretics work by antagonizing the effects of aldosterone. They are often added to diuretic regimens to prevent hypokalemia; however, as a result, an adverse effect can be hyperkalemia. Overall, potassium-sparing diuretics will cause?
an increase in sodium excretion, a decrease in potassium excretion, and increase in water excretion.
The patient, who had a recent episode of mononucleosis, is presenting with signs of hemolytic anemia (eg, increased reticulocyte count, scleral icterus, decreased hemoglobin) with pain and discoloration of the extremities. The patient’s fatigue and lethargy are likely due to?
IgM-mediated (cold) autoimmune hemolytic anemia. This cold anemia may manifest soon after Epstein-Barr virus infection, also known as infectious mononucleosis (IM), or mono. It may also occur in the acute stage of HIV, in Mycoplasma pneumoniae infection, and in leukemia. Agglutination of red blood cells in the periphery may result in painful gray or purple discoloration of the fingers caused by cold exposure, as seen in this patient. A patient with chronic cold agglutinin disease will have more symptoms during the colder months.
Although similar to Raynaud phenomenon, cold agglutinin disease differs in appearance and mechanism. Raynaud phenomenon is caused by vasospasm, resulting in a triphasic color change from white to blue to red, based on vasculature response. The positive heterophile test result reinforces ?
the likelihood of IgM-mediated (cold) autoimmune hemolytic anemia associated with active IM. The heterophile test has a good sensitivity and an excellent specificity for IM. It normally yields a negative result once IM has resolved.
Aplastic anemia results in pancytopenia (eg, leukopenia, anemia, and thrombocytopenia). As a result, signs of hemolytic anemia, such as scleral icterus or an increased reticulocyte count, would not be present. A patient with disseminated intravascular coagulation would be in much more unstable condition and would be experiencing coagulopathies in the setting of sepsis, acute myelogenous leukemia, or obstetric complications. Although IgG (warm) mediated hemolytic anemia would present with similar laboratory abnormalities, mononucleosis is strongly associated with?
IgM-mediated hemolytic anemia.
Paroxysmal nocturnal hemoglobinuria typically presents with dark urine during the night with partial clearing during the day.
Cold agglutinin IgM-mediated hemolytic anemia is caused by antibodies directed to RBCs and often follows infection with Epstein-Barr virus, Mycoplasma pneumoniae, leukemia, or HIV. Patients commonly present with?
signs of anemia, including painful gray or purple discoloration of the fingers exacerbated by cold exposure.
This patient has a past history of radiation therapy to the neck and now presents with a cold thyroid nodule. This information along with the fine-needle aspiration finding of a psammoma body (laminated concentric calcific spherules, the dark red circle to the lower right in the vignette image) suggests a diagnosis of?
papillary thyroid carcinoma (PTC).
PTC cells are characteristically large with overlapping nuclei containing finely dispersed chromatin, giving them a ground-glass appearance and central clearing, often termed “Orphan Annie-eye” nuclei, indicated by the arrow in this image. Numerous intranuclear inclusions and grooves can be seen due to invagination of the nuclear membrane (outlined in blue in this image), and psammoma bodies are commonly found.
PTC is the most common form of thyroid cancer, with an excellent prognosis. These patients present with an asymptomatic thyroid nodule in the neck and may have a history of previous radiation exposure (eg, treatment of childhood malignancies, nuclear power plant accidents). Patients with RET and BRAF mutations are also at increased risk of PTC. Remember that psammoma bodies may be found in other neoplasms and can be memorized with this mnemonic:?
PSaMMoma bodies: Papillary thyroid, Serous ovary, Meningioma, and Mesothelioma.
Anaplastic thyroid carcinoma occurs in older adults and appears histologically as poorly differentiated, pleomorphic cells on histology.
Follicular carcinoma is composed of ?
relatively small, uniform follicles with sparse colloid, lined with cells that are typically larger than those seen in a normal thyroid.
Medullary thyroid carcinoma appears histologically as polygonal to spindle-shaped cells with granular cytoplasm in an amyloid-filled stroma.
Thyroid lymphomas appear histologically as malignant lymphoid cells.
This patient presents after 3 weeks of fever and weight loss and exhibits pallor, hepatomegaly, and splenomegaly. These symptoms, along with her laboratory test results, are consistent with ?
hemophagocytic lymphohistiocytosis (HLH), which is confirmed by the bone marrow aspiration, demonstrating hemophagocytes. Hemophagocytes (red arrow in image) are macrophages that have engulfed red blood cells (RBCs) and lymphocytes. Familial-type HLH is an autosomal recessive defect in several genes, including perforin-related genes, whereas the secondary type is frequently due to infection with Epstein-Barr virus. HLH involves the abnormal activation and proliferation of lymphohistiocytes, leading to hemophagocytosis and the upregulation of proinflammatory cytokines. The immune system becomes overstimulated and can begin attacking native cells in the bone marrow (as seen in the image in the vignette), the liver, and brain. Treatment consists of a combination of etoposide, corticosteroids, and methotrexate, although stem cell transplantation is often required.
Ewing sarcoma usually presents in the second decade of life with fever, weight loss, bone tenderness, and pathologic fractures. This patient is only 2 years old, and bone marrow aspiration from a patient with Ewing sarcoma would not demonstrate the findings shown in the image.
Multiple myeloma presents in the elderly with renal injury, pathologic fractures, and hypercalcemia. A bone marrow aspirate would show red blood cells (RBCs) in rouleaux formation, stacks of RBCs pushed together by excessive protein, in contrast to this patient’s findings.
Neuroblastoma manifests with?
constitutional symptoms (fever, weight loss, pallor, hepatosplenomegaly), hypertension, abdominal pain, and an abdominal mass. These symptoms are not consistent with this patient’s presentation.
Wilms tumor manifests as an asymptomatic flank mass and/or gross hematuria.
Autoimmune lymphoproliferative syndrome is a rare inherited disorder of apoptosis, which is most commonly due to mutations in the FAS gene. Like HLH, it presents with chronic lymphadenopathy, splenomegaly, and symptomatic cytopenias in an otherwise healthy child. Although specific tests are required to rule out this diagnosis, the ferritin level is typically less than 3000 µg/L, as opposed to the highly elevated ferritin level seen in this patient.
Hemophagocytic lymphohistiocytosis can be identified on a bone marrow aspirate by the presence of macrophages engulfing RBCs. Treatment consists of ?
etoposide, methotrexate, and corticosteroids.
This patient presents with symptoms including daytime sleepiness, cataplexy, and sleep paralysis, some of the classic symptoms of narcolepsy. Cataplexy is defined as brief episodes of bilateral weakness brought on by strong emotions such as laughing or fear, without alteration in consciousness. Sleep paralysis is an episode of partial or total paralysis that occurs at the beginning or end of a sleep cycle. Patients are often aware that they are awake but may suffer from frightening hallucinations, called hypnagogic when they occur at sleep onset and hypnopompic when they occur on awakening.
Narcolepsy is associated with low CSF levels of hypocretin-1 (orexin A) and hypocretin-2 (orexin B). These neuropeptides are produced in the lateral hypothalamus and play a function in promoting wakefulness, but are low in narcolepsy due to?
destruction of the neurons that produce them.
Modafinil, an atypical dopamine reuptake blocker, is used to treat narcolepsy, although its exact mechanism of action is unknown. Patients suffering from cataplexy may also be treated with sodium oxybate.
The other medications are not used in the treatment of narcolepsy. Ethosuximide is used for managing absence seizures. Hydroxyzine is used for?
treating anxiety and insomnia. Prochlorperazine is a typical antipsychotic. Zolpidem is used for treating insomnia.
Narcolepsy is characterized by daytime sleepiness, cataplexy, sleep paralysis, and hypnagogic and hypnopompic hallucinations. It is treated with ?
modafinil.